Stay updated on Efpeglenatide Cardiovascular Outcomes Clinical Trial

Sign up to get notified when there's something new on the Efpeglenatide Cardiovascular Outcomes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efpeglenatide Cardiovascular Outcomes Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s site revision indicator changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T13:21:12.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH website changes and explains that some NIH content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    0.4%
    Check dated 2026-10-25T13:11:47.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:19:31.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site footer identifies the ClinicalTrials.gov interface as revision v3.7.1 rather than v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T14:34:47.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Adds a new revision entry for v3.7.0 to the study history. Removes the previous v3.6.6 entry, reflecting an updated version in the record history.
    Difference
    0.1%
    Check dated 2026-09-20T19:51:56.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    A new revision, v3.6.6, has been added to the record history. The previous revision v3.6.5 has been removed from the history list.
    Difference
    0.1%
    Check dated 2026-08-30T05:36:18.000Z thumbnail image

Stay in the know with updates to Efpeglenatide Cardiovascular Outcomes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efpeglenatide Cardiovascular Outcomes Clinical Trial page.